bupivacaine has been researched along with lopinavir in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cavalli, RC; Duarte, G; Lanchote, VL; Moisés, ECD; Moreira, FL; Quintana, SM; Ribeiro, RMP | 1 |
2 other study(ies) available for bupivacaine and lopinavir
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.
Topics: Adult; Amniotic Fluid; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Bupivacaine; Case-Control Studies; Cesarean Section; Drug Combinations; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Maternal-Fetal Exchange; Permeability; Placenta; Pregnancy; Pregnancy Complications, Infectious; Ritonavir | 2018 |